Accutane tied to IBD
Roche Holding AG, a Swiss drug manufacturer with U.S. operations in Nutley, New Jersey, has been ordered to pay $2.5 million in damages to a 36-year-old man who developed severe Inflammatory Bowel Disease (IBD) after taking the acne medication Accutane.
IBD refers to chronic diseases that cause inflammation in the form of painful swelling and diarrhea. Other common symptoms of IBD are abdominal cramps, blocked bowels, bloody stool, fever, dehydration, and extreme weight loss. IBD is also considered to be a major risk factor for developing colon and/or rectal cancer. Once you have IBD, symptoms can flare up without warning leaving sufferers constantly worried about when the next episode of pain and diarrhea will strike.
Accutane is a very powerful acne medication that Andrew McCarrell took in 1995. After taking the drug, he developed chronic diarrhea and incontinence, and, after multiple surgeries, finally had to have his colon removed. McCarrell was awarded $2.5 million and an additional $119,000 to cover his medical expenses. To date, there have been approximately 400 lawsuits in the United States involving Accutane, which has been on the market since 1982.